Oupeptide
Finnrick has tested 150 samples from Oupeptide across 8 products.
Finnrick Vendor Profile
to
Oupeptide
Tracking 8 products
150 total samples tested
Last test 4 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 7 | 21 Aug 2025 | 26 Jan 2026 | |||||
| GHK-Cu | 8 | 14 Aug 2025 | 18 Feb 2026 | |||||
| BPC-157 | 8 | 15 Aug 2025 | 9 Feb 2026 | |||||
| Retatrutide | 53 | 9 Jun 2025 | 4 Mar 2026 | |||||
| Semaglutide | 6 | 5 Aug 2025 | 29 Jan 2026 | |||||
| Tesamorelin | 10 | 10 Aug 2025 | 4 Mar 2026 | |||||
| Tirzepatide | 57 | 3 Jun 2025 | 4 Mar 2026 | |||||
| PT-141 | 1 | 24 Jul 2025 | 24 Jul 2025 | |||||
The Oupeptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.9
Based on 12 overall satisfaction reports
Ease of Purchase4.7(12)
Payment Methods4.6(12)
Delivery Speed4.7(12)
Packaging Quality4.6(12)
Customer Service4.9(11)
People who submitted test requests to Finnrick gave Oupeptide an average satisfaction rating of 4.9 out of 5 across 12 reports associated with samples received and tested by Finnrick.
Most recent Oupeptide tests
Samples are tested in commercial labs
150
tests
8
products
Scores
AVGMINMAX
First
3 Jun 2025
Last
4 Mar 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 4 Mar 2026 | Tirzepatide | View | 10mg | 10.2mg | +2.0% | 99.89% | below LOQ | Jan, 14 2026 | No Label / Silver Crimp / Yellow Cap | Lab E | Public | |
| 4 Mar 2026 | Retatrutide | View | 30mg | 35.2mg | +17.3% | 99.80% | n/a | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab G | Public | |
| 4 Mar 2026 | Tesamorelin | View | 20mg | 0.1mg | -99.5% | 80.00% | n/a | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab G | Public | |
| 2 Mar 2026 | Tirzepatide | View | 20mg | 16.7mg | -16.5% | 99.90% | n/a | PL-PURPLE TOP | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 1 Mar 2026⚠️ | Tirzepatide | View | 30mg | 28.6mg | -4.7% | 99.80% | n/a | Dec 2, 2025 | No Label / Silver Crimp / Pink Cap | Lab G | Public | |
| 26 Feb 2026 | Tesamorelin | View | 5mg | 5.13mg | +2.6% | 99.00% | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 26 Feb 2026 | Retatrutide | View | 15mg | 15.1mg | +0.7% | 98.14% | n/a | (no batch ID) | No Label / Silver Crimp / Clear Cap | Lab E | Public | |
Corrections
- 26 Dec 2025: Tirzepatide
- Submitter indicated having swapped vendor identification with sample u4q3pap. This should be OUPeptide instead of Quenna PMQ. Evidence under review, ratings might be updated.